• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ALLERGAN (PRINGY) VOLIFT WITH LIDOCAINE; IMPLANT, DERMAL, FOR AESTHETIC USE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ALLERGAN (PRINGY) VOLIFT WITH LIDOCAINE; IMPLANT, DERMAL, FOR AESTHETIC USE Back to Search Results
Catalog Number 94703RX
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Inflammation (1932); Skin Irritation (2076)
Event Date 10/11/2020
Event Type  Injury  
Manufacturer Narrative
Further information regarding event, product, or patient details has been requested.No additional information is available at this time.The event is a physiological complication and analysis of the device generally does not assist allergan in determining a probable cause for this event.Clarification: the filler was injected into the patient and is not accessible for return.The syringe was not returned for evaluation.A review of the device history record has been initiated.If any new, changed or corrected information is noted, a supplemental medwatch will be submitted.This is a known potential adverse event addressed in the product labeling.
 
Event Description
Healthcare professional reported a patient was injected with juvéderm® voluma¿ with lidocaine in the malar (ck1, ck2) and mentonian (c1) regions with 1ml of juvéderm® voluma¿ with lidocaine and on the upper lip and groove with 1ml of juvéderm® volift¿ with lidocaine.10 days post-op, patient developed edema on the left upper lip.There is evidence of hardening of the product in the patient's body.The patient is under clinical medical treatment for the dilution (with hyaluronidase) of the injected product and treatment for pain.Patient also developed edema in the c1 region and no edema in the malar regions.The next day, patient was treated with predsim 20mg/day plus alektos 20mg/days but ¿the hardening worsened.¿ 3 days later, the dosage for predsim was increased and started clavulin.4 days later, patient had hardened nodules in the corners of the mouth and on the upper lip, ¿as a late reaction, related to the immunogenicity of the product." a week later, patient went to another office for a 2nd opinion and was prescribed antibiotics and corticoid.An ultrasound was performed 3 days after seeing another physician.Ultrasound did not show any abscess.Hyaluronidase was applied.Approximately 3 weeks later, patient symptoms has not been resolved with improvement of the edema, but still with palpable nodules in the groove and edema in the upper left lip.Hyaluronidase infiltration was performed again with triancil and anesthetic in the upper lip, lower lip on the left, and right and left nasolabial groove.Treatment was noted as led performed for 1 hour a few times with infiltration of hyaluronidase, triancil and anesthetic in the upper and lower lip, left side.Approximately a week later, patient presented significant improvement of lip edema.However, event has not completely resolved.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
VOLIFT WITH LIDOCAINE
Type of Device
IMPLANT, DERMAL, FOR AESTHETIC USE
Manufacturer (Section D)
ALLERGAN (PRINGY)
route de promery
zone artisanale de pre-mairy
pringy 74370
FR  74370
Manufacturer (Section G)
ALLERGAN (PRINGY)
route de promery
zone artisanale de pre-mairy
pringy 74370
FR   74370
Manufacturer Contact
michelle burgess
12331-a riata trace parkway
building 3
austin, TX 78727
7372473605
MDR Report Key11008952
MDR Text Key221563261
Report Number3005113652-2020-00786
Device Sequence Number1
Product Code LMH
Combination Product (y/n)Y
Reporter Country CodeBR
PMA/PMN Number
P110033
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Reporter Occupation Physician
Type of Report Initial
Report Date 12/14/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received12/15/2020
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date10/31/2021
Device Catalogue Number94703RX
Device Lot NumberV17LA90749
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received11/16/2020
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Treatment
JUVÉDERM® VOLUMA¿ WITH LIDOCAINE.
Patient Outcome(s) Required Intervention;
Patient Age49 YR
-
-